Rx only · Tablet · Sublingual

Buprenorphine And Naloxone

Buprenorphine Hydrochloride + Naloxone Hydrochloride Dihydrate

13 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US32 NDCs
13 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCN02AE01

RxCUI (US)1819

US makers13 labelers

Packages70

DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.527

Latest avg · Jul 22, 2026

-12%

Since Dec 17, 2025

Active US suppliers

66%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

290K

Rx · 2026 Q1

10.6M

Units dispensed

-31%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Bryant Ranch Prepack	repackager	40	SUPPLYING
Ascend Laboratories, LLC	unknown	6	SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.	unknown	4	SUPPLYING
Amneal Pharmaceuticals LLC	unknown	4	SUPPLYING
AvPAK	unknown	2	SUPPLYING
American Health Packaging	unknown	2	SUPPLYING
Redpharm Drug	unknown	2	SUPPLYING
Rhodes Pharmaceuticals LLC	unknown	2	SUPPLYING
Actavis Pharma, Inc.	unknown	2	SUPPLYING
Lannett Company, Inc.	unknown	2	SUPPLYING
Camber Pharmaceuticals, Inc.	unknown	2	SUPPLYING
Unit Dose Solutions, Inc.	unknown	1	SUPPLYING
REMEDYREPACK INC.	repackager	1	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Oct 18, 2022
RECALLRecall (Class II): Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutica…
Presence of Foreign Substance — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide with the United States